Nabil Chehab is an Executive Director in Medical Affairs, currently serving as the Lung Cancer Medical Franchise Head at AstraZeneca. With a strong background in Oncology, Biomarkers, Biotechnology, and Drug Development, Nabil has demonstrated expertise in launching new immuno-oncology drugs and developing medical strategies within the field. Nabil's academic credentials include a Ph.D. in Biochemistry & Biophysics from the University of Pennsylvania, an MBA in Management and Finance from NYU Stern School of Business, and a B.S. in Biochemistry & Biophysics from Oregon State University. Prior roles include positions at Bristol-Myers Squibb, Memorial Sloan-Kettering Cancer Center, and ImClone Systems.
This person is not in the org chart
This person is not in any teams
This person is not in any offices